131926-99-3
131926-99-3 structure
- Name: Lansoprazole Sulfone
- Chemical Name: Lansoprazole Sulfone
- CAS Number: 131926-99-3
- Molecular Formula: C16H14F3N3O3S
- Molecular Weight: 385.361
- Catalog: Signaling Pathways Membrane Transporter/Ion Channel Proton Pump
- Create Date: 2018-08-14 07:52:14
- Modify Date: 2026-07-03 18:53:52
-
Lansoprazole sulfone (AG-1813) is an orally active and selective inhibitor of H+, K+-ATPase. Lansoprazole sulfone can significantly stimulates gastric acid secretion by inhibiting H+, K+-ATPase. Lansoprazole sulfone has potential applications in duodenal ulcer, gastric ulcer, gastroesophageal reflux disease and Zolinger Ellison disease[1][2].
| Name | Lansoprazole Sulfone |
|---|---|
| Synonyms |
Lansoprazole Sulphone
1H-BenziMidazole, 2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]Methyl]sulfonyl] Lansoprazole sulfone - Bio-X Lansoprazole Impurity B/Impurity A Lansoprazole Impurity B (Sulphone) Lansoprazole Related Compound A (25 mg) (2-[[[3-methyl-4-(2,2,2-triflouroethoxy)-2-pyridyl]methyl]sulfonyl]benzimidazole) Lansoprazole SulfoneDiscontinued See: L175026 Lansoprazole sulfoneQ: What is Lansoprazole sulfone Q: What is the CAS Number of Lansoprazole sulfone Q: What is the storage condition of Lansoprazole sulfone Q: What e the applications of Lansoprazole sulfone Lansoprazole impurity 2/Lansoprazole Impurity B/Lansoprazole Sulfone/2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl]sulfonyl]-1H-benzimidazole 2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfonyl]-1H-benzimidazole 2-[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridylmethylsulfonyl]-1H-benzimidazole RC A)Cat No Lansoprazole Related Compound A (or) imp B Lansoprazole Impurity B（） Lansoprazole Related Compound A Lansoprazole Impurity B Lansoprazole Related Compound A Lansoprazole related substance B 2-(((3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl)sulfonyl)-1H-benzo[d]imidazole Lansoprazole Sulfone / Lansoprazole Impurity-B LANSOPRAZOLE SULFONE Lansoprazole Impurity Ⅱ/Lansoprazole sulfone Lansoprazole IMpurity B 2-({[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl}sulfonyl)-1H-benzimidazole 2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfonyl]-1H-benzimidazole Lansoprazole Impurity B/ Lansoprazole Related Compound A (Lansoprazole Sulfone) Lansoprazole-2 Lansoprazole Related CoMpound A 2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl]sulphonyl]-1H-benzimidazole (Lansoprazole 2-[[[3-Methyl-4-(2,2,2-triflouroethoxy)-2-pyridyl]Methyl]sulfonyl]benziMidazole Lansoprazole Impurity 2(Lansoprazole Impurity B) Dex-Lansoprazole Sulfone/Lansoprazole Impurity B /Lansoprazole Related Compound A 2-[[[3-Methyl-4-(2,2,2-trifluoroeth 2-[[4-(2,2,2-Trifluoroethoxy)-3-methylpyridine-2-yl]methylsulfonyl]-1H-benzoimidazole Lansoprazole Impurity Ⅱ Lansoprazole sulfone, 10 mM in DMSO Lansoprazole IMpurity B (Lansoprazole Sulfone) 1H-Benzoimidazole-2-yl[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl] sulfone |
| Description | Lansoprazole sulfone (AG-1813) is an orally active and selective inhibitor of H+, K+-ATPase. Lansoprazole sulfone can significantly stimulates gastric acid secretion by inhibiting H+, K+-ATPase. Lansoprazole sulfone has potential applications in duodenal ulcer, gastric ulcer, gastroesophageal reflux disease and Zolinger Ellison disease[1][2]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 555.6±60.0 °C at 760 mmHg |
| Melting Point | 207ºC(dec.) |
| Molecular Formula | C16H14F3N3O3S |
| Molecular Weight | 385.361 |
| Flash Point | 289.8±32.9 °C |
| Exact Mass | 385.070801 |
| PSA | 93.32000 |
| LogP | 4.46 |
| Vapour Pressure | 0.0±1.5 mmHg at 25°C |
| Index of Refraction | 1.581 |
| RIDADR | NONH for all modes of transport |
|---|